These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38680585)

  • 1. Metabolic syndrome and the urinary microbiome of patients undergoing percutaneous nephrolithotomy.
    Dornbier RA; Doshi CP; Desai SC; Bajic P; Van Kuiken M; Khemmani M; Farooq AV; Bresler L; Turk TMT; Wolfe AJ; Baldea KG
    Asian J Urol; 2024 Apr; 11(2):316-323. PubMed ID: 38680585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The microbiome of calcium-based urinary stones.
    Dornbier RA; Bajic P; Van Kuiken M; Jardaneh A; Lin H; Gao X; Knudsen B; Dong Q; Wolfe AJ; Schwaderer AL
    Urolithiasis; 2020 Jun; 48(3):191-199. PubMed ID: 31240349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The microbiome of kidney stones and urine of patients with nephrolithiasis.
    Lemberger U; Pjevac P; Hausmann B; Berry D; Moser D; Jahrreis V; Özsoy M; Shariat SF; Veser J
    Urolithiasis; 2023 Jan; 51(1):27. PubMed ID: 36596939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of visceral fat area and other metabolic parameters on stone composition in patients undergoing percutaneous nephrolithotomy.
    Zhou T; Watts K; Agalliu I; DiVito J; Hoenig DM
    J Urol; 2013 Oct; 190(4):1416-20. PubMed ID: 23685097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of metabolic syndrome in bilateral upper urinary tract stones: A retrospective study of 3905 cases.
    Li Z; Fu C; Sun C; Suo Y; Li K; Qi S
    Heliyon; 2024 May; 10(10):e31180. PubMed ID: 38803979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Specific immunization for the prevention of recurrent nephrolithiasis after percutaneous nephrolithotomy].
    Pushkarev AM; Hamidullin KR; Papojan AO; Rakipov IG; Kazihinurov AA; Zagitov AR; Pavlov VN
    Urologiia; 2020 Dec; (6):82-88. PubMed ID: 33377684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple sclerosis and nephrolithiasis: a matched-case comparative study.
    Ganesan V; Chen WM; Jain R; De S; Monga M
    BJU Int; 2017 Jun; 119(6):919-925. PubMed ID: 28220601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Number of Metabolic Syndrome Components Is the Central Predictor of the Impact of Metabolic Syndrome on Outcome of Percutaneous Nephrolithotomy in Staghorn Nephrolithiasis.
    Xu P; Wang J
    J Endourol; 2019 Nov; 33(11):946-953. PubMed ID: 31333070
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolic stone workup abnormalities are not as important as stone culture in patients with recurrent stones undergoing percutaneous nephrolithotomy.
    Ahmed AE; Abol-Enein H; Awadalla A; Shokeir AA; El-Shehaby OA; Harraz AM
    Urolithiasis; 2023 Mar; 51(1):47. PubMed ID: 36913043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metabolic syndrome and nephrolithiasis].
    Kohjimoto Y; Iba A; Sasaki Y; Hara I
    Hinyokika Kiyo; 2011 Jan; 57(1):43-7. PubMed ID: 21304261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome and urinary stone composition: what factors matter most?
    Kadlec AO; Greco K; Fridirici ZC; Hart ST; Vellos T; Turk TM
    Urology; 2012 Oct; 80(4):805-10. PubMed ID: 22795374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome: a multifaceted risk factor for kidney stones.
    Domingos F; Serra A
    Scand J Urol; 2014 Oct; 48(5):414-9. PubMed ID: 24708398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bladder stones after bladder augmentation are not what they seem.
    Szymanski KM; Misseri R; Whittam B; Lingeman JE; Amstutz S; Ring JD; Kaefer M; Rink RC; Cain MP
    J Pediatr Urol; 2016 Apr; 12(2):98.e1-6. PubMed ID: 26455637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extensive characterizations of bacteria isolated from catheterized urine and stone matrices in patients with nephrolithiasis.
    Tavichakorntrakool R; Prasongwattana V; Sungkeeree S; Saisud P; Sribenjalux P; Pimratana C; Bovornpadungkitti S; Sriboonlue P; Thongboonkerd V
    Nephrol Dial Transplant; 2012 Nov; 27(11):4125-30. PubMed ID: 22461670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Urine Findings with Metabolic Syndrome Traits in a Population of Patients with Nephrolithiasis.
    Hood VL; Sternberg KM; de Waal D; Asplin JR; Mulligan C; Callas PW
    Kidney360; 2022 Feb; 3(2):317-324. PubMed ID: 35373120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and relevance of urine culture during stone fragmentation in patients undergoing percutaneous nephrolithotomy and retrograde intrarenal surgery: a prospective study.
    De Lorenzis E; Boeri L; Gallioli A; Fontana M; Zanetti SP; Longo F; Colombo R; Arghittu M; Piconi S; Albo G; Trinchieri A; Montanari E
    World J Urol; 2021 Jun; 39(6):1725-1732. PubMed ID: 32734462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study on bacteria within stones in urolithiasis].
    Oka T; Hara T; Miyake O; Hosomi M; Matsumiya K; Takaha M; Tanaka M; Funahashi S; Toyomasu T; Kimura M
    Hinyokika Kiyo; 1989 Sep; 35(9):1469-74. PubMed ID: 2816611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a distinct gut microbiome in kidney stone formers compared to non-stone formers.
    Stern JM; Moazami S; Qiu Y; Kurland I; Chen Z; Agalliu I; Burk R; Davies KP
    Urolithiasis; 2016 Oct; 44(5):399-407. PubMed ID: 27115405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What Factors Drive Staghorn
    Winoker JS; Bamberger JN; Chandhoke RA; Atallah W; Gupta M
    J Endourol; 2019 Nov; 33(11):954-959. PubMed ID: 31436119
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dual-energy computed tomography in the diagnostics of urolithiasis].
    Kapanadze LB; Rudenko VI; Serova NS; Rapoport LM; Aleksandrova KA; Novikov AA
    Urologiia; 2019 Dec; (5):31-36. PubMed ID: 31808629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.